Special Drug Use Surveillance of Rozlytrek Capsule in Pediatric Patients - Advanced or recurrent solid tumors with NTRK gene fusions -
Latest Information Update: 08 Jan 2022
At a glance
- Drugs Entrectinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical
- 08 Sep 2020 New trial record
- 04 Sep 2020 Status changed from not yet recruiting to recruiting.